chrysler xtrst, chrysler hd, chrysler grand coupe, chrysler grand caravan, chrysler gs, chrysler grand voyager, chrysler passenger car, chrysler, vehicle weight/class & GVWR.
See also
List of American cars
References
External links
C.D.A. database
Chrysler Direct Owners Manual
Category:Chrysler platforms(Reuters) - William Connell, the former CEO of Amgen Inc AMGN.O, is under investigation by the U.S. Securities and Exchange Commission for his role in a partnership that allowed the company to trade in its own stock without registering with the SEC.
FILE PHOTO - A sign for Amgen is seen in front of the company's facility in South San Francisco, California, U.S., April 18, 2018. REUTERS/Stephen Lam
The investigation, which could eventually lead to a lawsuit against the former CEO and the now-defunct Big Point Medical LLC, comes as the SEC faces increasing scrutiny from Congress over its oversight of the $1.3 trillion U.S. stock market.
Connell, who retired from Amgen in October, said the SEC was looking into the allegations but would not comment further.
A spokeswoman for the SEC declined to comment.
Big Point, which was headquartered in Bridgeport, Connecticut, was an alternative trading system, or ATS, that Amgen launched in 2014, according to an SEC filing. The ATS made it easier for Amgen to use its own stock to raise money, as it had done before.
It also made it easier for small investors to trade Amgen’s shares because they were able to buy and sell the shares electronically, according to the SEC.
Amgen took the unusual step of allowing Big Point to trade in its own shares because the company was concerned about a long-standing SEC rule that says large block sellers of shares cannot register with the agency, according to the SEC.
It allowed Big Point to be exempt from the rule as long as it had a director who was a qualified auditor and whose financial statements were publicly filed.
One of Big Point’s directors was KPMG LLP, the same accounting firm that audited Amgen’s 2016 annual report and was also one of Amgen’s outside auditors for the Big Point deal, the SEC said.
Related links:
Comentarios